Key Insights

Highlights

Success Rate

100% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 40/100

Termination Rate

0.0%

0 terminated out of 4 trials

Success Rate

100.0%

+13.5% vs benchmark

Late-Stage Pipeline

25%

1 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

4Total
Not Applicable (2)
P 1 (1)
P 4 (1)

Trial Status

Completed1
Not Yet Recruiting1
Recruiting1
Withdrawn1

Trial Success Rate

100.0%

Benchmark: 86.5%

Based on 1 completed trials

Clinical Trials (4)

Showing 4 of 4 trials
NCT06834204Not ApplicableNot Yet Recruiting

Advancing Care Coordination Between Cancer and Primary Care Teams for Complex Cancer Survivors

NCT06789432Phase 4RecruitingPrimary

Efficacy and Safety of Atorvastatin and Ezetimibe (10/10mg) Fixed Dose Combination Versus Atorvastatin (20mg) Monotherapy in Bangladeshi Population

NCT05704439Not ApplicableWithdrawn

Cardiovascular Risk Reduction in Epilepsy

NCT05460364Phase 1Completed

A Study to Evaluate the Pharmacokinetic Interaction and Safety Between BR1018-1 and BR1018-2 in Healthy Adult Subjects

Showing all 4 trials

Research Network

Activity Timeline